Clinical Trial Update: Effectiveness and Safety of Enbrel® (Etanercept) in Rheumatoid Arthritis Subjects Who Have Failed Remicade® (Infliximab) [Phase 4]

View source ↗

Summary

Phase 4 study assessing the effectiveness and safety of Enbrel (etanercept) in rheumatoid arthritis patients who failed Remicade (infliximab).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ENBREL (etanercept)
• Remicade (infliximab)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis | Phase 4 | Status: COMPLETED